DanCann Pharma A/S’ shares start buying and selling on the OTCQB enterprise market in the US

0
77

COPENHAGEN, Denmark, 5 December 2022 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), a Danish firm powered by cannabinoids, hereby broadcasts that the Company has been welcomed by OTC Markets Group for buying and selling on OTCQB within the US – an vital step for DanCann Pharma into the US capital markets enhancing entry for US-Investors to DCPXF-shares.

DanCann Pharma has been authorized and certified to commerce on the OTCQB Venture Market underneath the image “DCPXF”. OTC Markets Group is an operator of regulated markets for buying and selling 12,000 US and worldwide securities offering worldwide corporations with the chance to make their shares extra simply accessible to US buyers. US buyers can now discover the present monetary disclosures and real-time degree two (2) quotes for DanCann Pharma on www.otcmarkets.com.

The buying and selling on OTCQB marks an vital step for DanCann Pharma in offering extra clear buying and selling and tapping demand from US buyers. The objective is to extend visibility and accessibility within the US capital market thereby offering better liquidity and worth to the Company’s shareholders.

Jeppe Krog Rasmussen, Founder and CEO of DanCann Pharma, feedback:

– The timing is ideal. We have simply acquired EU-GMP-approval of our high-end manufacturing amenities Biotech Pharm1 and is able to begin manufacturing of biomaterial for export. As we proceed to develop and want to place DanCann Pharma as a number one contributor to the medicinal hashish market, we now have skilled appreciable curiosity over time within the Company from US-based buyers. To leverage on this curiosity and improve visibility and accessibility within the US capital market, we determined to hitch the OTCQB market. We are trying ahead to the alternatives this can carry to the Company, in addition to the worth we consider it is going to carry for our shareholders.

As DanCann Pharma is listed on a professional international alternate already (Spotlight Stock Market), the streamlined market requirements allow DanCann Pharma to make the most of the house market reporting to make firm info obtainable within the US by way of OTCQB. To qualify for buying and selling, DanCann Pharma has meet monetary requirements, observe finest follow company governance, and has demonstrated compliance with relevant safety legal guidelines.

Shares traded on the OTCQB market is sourced through the Spotlight Stock Market (Scale Segment), which is anticipated to have a constructive impact on the general buying and selling of the DanCann Pharma shares. Joining the OTCQB enterprise market will facilitate US buyers to commerce in DanCann Pharma’s atypical share in US {dollars}, with a US ticker image (DCPXF), and through US market hours.

Jeppe Krog Rasmussen feedback:

– DanCann Pharma is uniquely positioned as a Danish/European firm working inside medicinal hashish and therapeutic cannabinoids. The firm is just not backed by three way partnership constellations or different funding from the USA or Canada. DanCann Pharma already maintain quite a lot of permits and has signed collaboration agreements with producers and distributors in Europa and North America. We consider there’s latent curiosity on the US markets to put money into our Company’s progress.

DanCann Pharma’s share stays listed – and can proceed to commerce – on the Spotlight Stock Exchange and no new atypical shares might be issued as a part of the method. Joining the OTCQB enterprise market will permit simpler buying and selling entry for US buyers, which the corporate believes will improve liquidity and income within the share in addition to the chance to broaden the shareholder base. North America is a world chief inside biotech and hashish which makes investing in a longtime and fast-moving Danish market contributor much more related. 

Jeppe Krog Rasmussen elaborates:

– So far, we now have had a profitable journey based mostly on a lot of loyal buyers. However, as DanCann Pharma is rising in measurement and professionality, we want to replicate this in our investor-base. We hope that our introduction within the US enterprise market will open for quite a lot of semi- institutional and sooner or later trying in the direction of extra institutional buyers. The OTCQB twin citation marks an vital step in our effort to supply US buyers with simpler entry to the DanCann Pharma share. US buyers can now – lastly – commerce the DanCann Pharma share in US {dollars} and through US hours.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for buying and selling 12,000 U.S. and worldwide securities. Our data-driven disclosure requirements type the muse of our three public markets: OTCQX(R) Best Market, OTCQB(R) Venture Market and Pink(R) Open Market. Our OTC Link(R) Alternative Trading Systems (ATSs) present important market infrastructure that broker-dealers depend on to facilitate buying and selling. Our revolutionary mannequin presents corporations extra environment friendly entry to the U.S. monetary markets. OTC Link ATS, OTC Link ECN and OTC Link NQB are every an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC. To study extra about how we create higher knowledgeable and extra environment friendly markets, go to www.otcmarkets.com. 

About DanCann Pharma

DanCann Pharma A/S (SS: DANCAN) was based in 2018 and is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a vertically built-in, licensed manufacturing and distribution Company based mostly in Denmark. The Company focuses on discovering, creating, manufacturing, and commercializing new therapeutic cannabinoids in a variety of illness areas. DanCann Pharma A/S (SS: DANCAN) is listed on the Spotlight Stock Market in Copenhagen.

For extra info, go to: www.dancann.com.

For additional info, please contact:

Jeppe Krog Rasmussen, CEO

E-mail: jkr@dancann.com  

Website: www.dancann.com  

Forward trying assertion

Some statements on this launch might include forward-looking info. All statements, apart from of historic reality, that tackle actions, occasions, or developments that the Company believes, expects, or anticipates will or might happen sooner or later (together with, with out limitation, statements relating to potential acquisitions and financings) are forward-looking statements. Forward-looking statements are typically identifiable by use of the phrases “might”, “will”, “ought to”, “proceed”, “anticipate”, “anticipate”, “estimate”, “consider”, “intend”, “plan” or “undertaking” or the damaging of those phrases or different variations on these phrases or comparable terminology.

Forward-looking statements are topic to a number of dangers and uncertainties, a lot of that are past the Company’s capability to manage or predict, that will trigger the precise outcomes of the Company to vary materially from these mentioned within the forward-looking statements. Factors that would trigger precise outcomes or occasions to vary materially from present expectations embrace, amongst different issues, with out limitation, the lack of the Company, to acquire enough financing to execute the Company’s marketing strategy; competitors; regulation and anticipated and unanticipated prices and delays, the success of the Company’s analysis methods, the applicability of the discoveries made therein, the profitable and well timed completion and uncertainties associated to the regulatory course of, the timing and outcomes of regulatory or mental property choices and different dangers disclosed within the Company’s public disclosure file on file with the related securities regulatory authorities.

Although the Company has tried to establish vital components that would trigger precise outcomes or occasions to vary materially from these described in forward-looking statements, there could also be different components that trigger outcomes or occasions to not be as anticipated, estimated or supposed. Readers shouldn’t place undue reliance on forward-looking statements. The forward-looking statements included on this presentation are made as of the date of this presentation and the Company doesn’t undertake an obligation to publicly replace such forward-looking statements to replicate new info, subsequent occasions or in any other case except required by relevant securities laws.

https://information.cision.com/dancann-pharma/r/dancann-pharma-a-s–shares-commence-trading-on-the-otcqb-venture-market-in-the-united-states,c3677334

https://mb.cision.com/Main/19875/3677334/1713783.pdf

(c) 2022 Cision. All rights reserved., supply Press Releases – English

LEAVE A REPLY

Please enter your comment!
Please enter your name here